Zeshan Muhammedi

Zeshan holds board roles at MBX partner companies Attivare Therapeutics, Cloudcath, Mae Health, AmacaThera, and SecureAire.  Previously, he was the CEO of FundRx, a healthcare and life sciences investment marketplace. Prior to FundRx, he was Managing Partner at Tensile Company, a venture advisory firm. At Tensile, he was an investor and advisor to plant genetics firm Ebbu, Inc (acquired in 2018 for $330mm) and worked with Torreya Partners, a life sciences investment bank, to launch AvaRx, an M&A research platform for the pharma industry.  He is an advisor to BrainMind, a consortium working to support advances in brain science. Zeshan earned his undergraduate degree from Emory University, and is a Kauffman Fellow.